US FDA approves injectable form of Bristol Myers' Opdivo

Halozyme Therapeutics

27/12/2024 16:30

Dec 27 (Reuters) - The U.S. Food and Drug Administration
said on Friday that it has approved an injectable version of
Bristol Myers Squibb's  BMY.N  blockbuster cancer drug, Opdivo.

 (Reporting by Sneha S K and Sriparna Roy in Bengaluru; Editing
by Pooja Desai and Shreya Biswas)
 ((Sneha.SK@thomsonreuters.com;))